Neuroplasticity and Psychedelics

Depression is more complex than just low serotonin levels, as evidenced by the effectiveness of antidepressants like bupropion. Both MDMA and psilocybin enhance neuroplasticity but do so through different mechanisms, highlighting the need for skilled guidance when exploring these substances for therapeutic purposes. The conversation also emphasizes the importance of understanding the distinct effects of these drugs on brain connectivity and plasticity.